- Status:
- In progress
- Technology type:
- Medicine
- Decision:
- Selected
- Reason for decision:
- Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
- Process:
- STA Standard
- ID number:
- 6525
Project Team
- Project lead
- Emily Richards
Email enquiries
If you have any queries please email [email protected]
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 24 April 2025 - 23 May 2025 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6525 |
| 21 May 2025 | Following an update from the company responsible for pridopidine, NICE will not be progressing with the scoping exercise at this time. The consultation on the draft scope will now close and the workshop arranged for Wednesday 25 June 2025 has been cancelled. Please accept our apologies for any inconvenience. As this evaluation has been referred to NICE, we will continue dialogue with the company and will update interested parties if the situation changes |
| 24 April 2025 | In progress. Scoping commenced. |
| 16 April 2025 | Referral |
| 08 October 2024 | Awaiting development. Status change linked to Topic Selection Decision being set to Selected |
| 08 October 2024 | Topic selection |
For further information on our processes and methods, please see our CHTE processes and methods manual